Stock 1783 MAXIGEN BIOTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Maxigen Biotech Inc.

Equities

1783

TW0001783009

Personal Products

End-of-day quote Taiwan S.E.
Other stock markets
 06:00:00 2024-05-02 pm EDT 		5-day change 1st Jan Change
42.9 TWD -0.23% Intraday chart for Maxigen Biotech Inc. +1.54% -11.36%
Mar. 21 Maxigen Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Maxigen Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Business Summary

MAXIGEN BIOTECH INC. is a Taiwan-based company principally engaged in the manufacture and sales of biological products, the wholesale of all kinds of medical equipment, medicines, foods, masks, skin care products, as well as the manufacture and sales of chemical materials. The Company operates through two main segments. The Consumer Products segment is mainly engaged in the wholesales of cleansing products, facial care products, medical beauty products and others. The Biomedical Products is mainly involved in the manufacture and sales of Formagraft collagen and ceramic composite material products, Foramic ceramic bone feed materials, Artiaid hyaluronic acid joint injection products, ViscAid ophthalmology viscoelastic agents, as well as SurgiAid wound collagen materials and others.

Sales per Business

TWD in Million2022Weight2023Weight Delta
Biomedical
103.6 %
560 92.6 % 645 103.6 % +15.16%
Adjustments and Write-offs
-6.9 %
- - -43 -6.9 % -
Consumer
3.3 %
45 7.4 % 20 3.3 % -54.34%

Sales per region

TWD in Million2022Weight2023Weight Delta
Taiwan
44.3 %
245 40.6 % 276 44.3 % +12.40%
Americas
32.0 %
190 31.4 % 199 32.0 % +4.84%
Asia
15.4 %
134 22.1 % 96 15.4 % -28.25%
Europe
4.5 %
30 5.0 % 28 4.5 % -7.38%
Others
3.8 %
6 1.0 % 24 3.8 % +306.59%

Managers

Managers TitleAgeSince
Jing Ting Chen CEO
 Chief Executive Officer - 21-11-02
Ruei Yi Wu DFI
 Director of Finance/CFO - 23-03-21
Yi Hua Yu DFI
 Director of Finance/CFO - 18-06-20
Cian Tian Huang IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Yong Xiang Lin CHM
 Chairman - 21-07-11
Xiu Yuan Li BRD
 Director/Board Member - 15-06-21
Zhen Zhen Fu BRD
 Director/Board Member - 21-07-11
Jing Ting Chen CEO
 Chief Executive Officer - 21-11-02
Song Yuan Liao BRD
 Director/Board Member - 21-07-11
Shih Ming Li BRD
 Director/Board Member - 21-07-11
Zhong Ming Zeng BRD
 Director/Board Member - 21-07-11
Tsong Jieh Chiou BRD
 Director/Board Member - 22-06-20
Shih Ming Lai BRD
 Director/Board Member - 22-06-20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 88,934,000 49,154,115 ( 55.27 %) 0 55.27 %

Shareholders

NameEquities%Valuation
BTG Pactual Asset Management S/A DTVM
0.008619 %
7,665 0.008619 % 10 945 NT$
DFA Australia Ltd.
0.000133 %
118 0.000133 % 169 NT$

Company contact information

Maxigen Biotech, Inc.

No. 88, Keji 1st Road Guishan District

333 83, Taoyuan

+

http://www.mbi.com.tw
address Maxigen Biotech Inc.(1783)

Sector

Consumer Non-Cyclicals
Personal & Household Products & Services
Personal &Household Products & Services
Personal Products
Cosmetics & Perfumes

Sales per Business

Sales per region

Sector Cosmetics & Perfumes

1st Jan change Capi.
MAXIGEN BIOTECH INC. Stock Maxigen Biotech Inc.
-11.36% 118M
L'ORÉAL Stock L'Oréal
-2.16% 254B
GALDERMA GROUP AG Stock Galderma Group AG
0.00% 18.26B
SHISEIDO COMPANY, LIMITED Stock Shiseido Company, Limited
+0.38% 11.16B
COTY INC. Stock Coty Inc.
-6.60% 10.38B
AMOREPACIFIC CORPORATION Stock Amorepacific Corporation
+16.34% 7.63B
PROYA COSMETICS CO.,LTD. Stock Proya Cosmetics Co.,Ltd.
+10.15% 5.97B
NATURA &CO HOLDING S.A. Stock Natura &Co Holding S.A.
+1.12% 4.65B
INTER PARFUMS, INC. Stock Inter Parfums, Inc.
-17.29% 3.81B
INTERPARFUMS Stock Interparfums
-5.56% 3.54B
Cosmetics & Perfumes
  1. Stock Market
  2. Equities
  3. 1783 Stock
  4. Company Maxigen Biotech Inc.